Media Requests

If you or your company/publication wish to receive additional media or have questions on another media related issue please fill out the form below.


Neuros Medical Announces Successful Pilot Study


 Cleveland, OH, June 4, 2013 – Neuros Medical, Inc., a medical device company announced significant results today from their long term pilot study. The study evaluated the Company’s patented on-demand, high frequency Electrical Nerve Block technology which focused on patients afflicted with chronic amputation pain. This debilitating condition affects nearly one million patients in the U.S. alone.

Results indicated that 7 out of 9 study subjects reported significant pain reduction (defined as 50% or greater) observed for up to 12 months of evaluation. The study demonstrated no safety issues over the treatment period. Study subjects reported an average pain score reduction of 6 to 1 (an 83% pain reduction) based on a 0 to 10 Numerical Rating Scale. Significant pain reduction was reported in 91% of all treatment sessions. In addition, more than half of the subjects discontinued their narcotic pain medication use during the study.